|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/4406 | (2006.01) |
| A61P 35/00 | (2018.01) | ||
| A61K 31/47 | (2006.01) | ||
| A61K 31/4406 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 31/47 | (2013.01) | ||
| A61K 9/16 | (2006.01) | ||
| A61K 9/2886 | (2013.01) | ||
| A61K 9/20 | (2006.01) | ||
| A61K 9/2893 | (2013.01) | ||
| A61K 9/28 | (2006.01) | ||
| A61K 9/1652 | (2013.01) | ||
| A61K 9/2054 | (2013.01) |
| (11) | Patento numeris | 3838273 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 19849696.0 |
| Europos patento paraiškos padavimo data | 2019-08-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2021-06-23 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-07-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2019/100175 |
| Data | 2019-08-12 |
| (87) | Numeris | WO 2020/034916 |
| Data | 2020-02-20 |
| (30) | Numeris | Data | Šalis |
| 201810943005 | 2018-08-17 | CN |
| (72) |
LU, Xianping , CN
NING, Zhiqiang , CN
ZHOU, You , CN
XIN, Lijun , CN
WANG, Yanan , CN
WANG, Shigang , CN
PAN, Desi , CN
SHAN, Song , CN
|
| (73) |
Shenzhen Chipscreen Biosciences Co., Ltd. ,
2-601~606
BIO-Incubator, Gaoxin C, 1st Ave.
Hi-Tech Industrial Park
Nanshan District, Shenzhen, Guangdong 518057,
CN
|
| (54) | COMBINATION OF CHIDAMIDE AND CHIAURANIB FOR USE IN THE TREATMENT OF HEPATOCELLULAR CARCINOMA |
| COMBINATION OF CHIDAMIDE AND CHIAURANIB FOR USE IN THE TREATMENT OF HEPATOCELLULAR CARCINOMA |